These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

231 related items for PubMed ID: 32039550

  • 1. DOAC plasma levels measured by chromogenic anti-Xa assays and HPLC-UV in apixaban- and rivaroxaban-treated patients from the START-Register.
    Cini M, Legnani C, Padrini R, Cosmi B, Dellanoce C, De Rosa G, Marcucci R, Pengo V, Poli D, Testa S, Palareti G.
    Int J Lab Hematol; 2020 Apr; 42(2):214-222. PubMed ID: 32039550
    [Abstract] [Full Text] [Related]

  • 2. An in vitro study to investigate the interference of enoxaparin on plasma levels of direct oral factor Xa inhibitors measured by chromogenic assays.
    Cini M, Legnani C, Testa S, Tripodi A, Cosmi B, Palareti G.
    Int J Lab Hematol; 2019 Jun; 41(3):309-315. PubMed ID: 30698331
    [Abstract] [Full Text] [Related]

  • 3. Using a low-molecular weight heparin-calibrated anti-factor Xa assay to assess the concentration of apixaban and rivaroxaban.
    von Horn H, Rasmusson A, Söderblom L, Malmström RE, Antovic J.
    Int J Lab Hematol; 2022 Feb; 44(1):163-167. PubMed ID: 34523813
    [Abstract] [Full Text] [Related]

  • 4. Assessment of low plasma concentrations of apixaban in the periprocedural setting.
    Lessire S, Dincq AS, Siriez R, Pochet L, Sennesael AL, Vornicu O, Hardy M, Deceuninck O, Douxfils J, Mullier F.
    Int J Lab Hematol; 2020 Aug; 42(4):394-402. PubMed ID: 32297711
    [Abstract] [Full Text] [Related]

  • 5. Preliminary report: Measurement of apixaban and rivaroxaban in plasma from bleeding patients.
    Jensen KOF, Hansen SH, Goetze JP, Jesting A, Stensballe J, Hansen H.
    Eur J Haematol; 2017 Nov; 99(5):431-436. PubMed ID: 28833682
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Comparison of the effect of the anti-Xa direct oral anticoagulants apixaban, edoxaban, and rivaroxaban on coagulation assays.
    Gosselin R, Grant RP, Adcock DM.
    Int J Lab Hematol; 2016 Oct; 38(5):505-13. PubMed ID: 27265752
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Chromogenic anti-FXa assay calibrated with low molecular weight heparin in patients treated with rivaroxaban and apixaban: possibilities and limitations.
    Margetić S, Ćelap I, Delić Brkljačić D, Pavlović N, Šupraha Goreta S, Kobasić I, Lovrenčić-Huzjan A, Bašić Kes V.
    Biochem Med (Zagreb); 2020 Feb 15; 30(1):010702. PubMed ID: 31839722
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Prospective cohort study on the use of low molecular weight heparin calibrated anti-Xa assay for measurement of direct oral Xa inhibitors in ex vivo patient samples.
    Lim MS, Hayes R, Sharma A, Kitiponchai T, Mohamed M, Mcrae S.
    Pathology; 2022 Aug 15; 54(5):599-605. PubMed ID: 35414442
    [Abstract] [Full Text] [Related]

  • 13. Factor Xa inhibitors in clinical practice: Comparison of pharmacokinetic profiles.
    Goto E, Horinaka S, Ishimitsu T, Kato T.
    Drug Metab Pharmacokinet; 2020 Feb 15; 35(1):151-159. PubMed ID: 32007354
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Dissociation between the pharmacokinetics and pharmacodynamics of once-daily rivaroxaban and twice-daily apixaban: a randomized crossover study.
    Kreutz R, Persson PB, Kubitza D, Thelen K, Heitmeier S, Schwers S, Becka M, Hemmrich M.
    J Thromb Haemost; 2017 Oct 15; 15(10):2017-2028. PubMed ID: 28805299
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Anti-Xa Oral Anticoagulant Plasma Concentration Assay in Real Life: Rivaroxaban and Apixaban Quantification in Emergency With LMWH Calibrator.
    Billoir P, Barbay V, Joly LM, Fresel M, Chrétien MH, Le Cam Duchez V.
    Ann Pharmacother; 2019 Apr 15; 53(4):341-347. PubMed ID: 30378443
    [Abstract] [Full Text] [Related]

  • 20. Heparin-Calibrated Anti-Factor Xa Assay for the Measurement of Direct Anticoagulants such as Apixaban, Rivaroxaban, and Edoxaban.
    Ahn HS, Chae H, Kim Y, Lee HK, Kim H.
    Clin Lab; 2024 Sep 01; 70(9):. PubMed ID: 39257123
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.